Advicenne S.A.

ALDVI Euronext / Paris Santé & Biotech Europe
1.09
0.37 %

Advicenne développe des solutions pharmacologiques pour le traitement de maladies rénales rares.

Performance & Momentum

6 Months 34.92 %
1 Year 37.60 %
3 Years 71.52 %
5 Years 86.93 %

Similar stocks to Advicenne S.A.

Anantys Community

Be the first to share your analysis on Advicenne S.A..

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases